Linden Thomas Advisory Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $948K | Sell |
7,551
-138
| -2% | -$17.3K | 0.1% | 292 |
|
|
2025
Q1 | $1.05M | Buy |
7,689
+662
| +9% | +$90.6K | 0.14% | 265 |
|
|
2024
Q4 | $1.07M | Sell |
7,027
-455
| -6% | -$69.6K | 0.14% | 267 |
|
|
2024
Q3 | $1.45M | Sell |
7,482
-4
| -0.1% | -$775 | 0.2% | 201 |
|
|
2024
Q2 | $1.74M | Buy |
7,486
+2,115
| +39% | +$490K | 0.27% | 130 |
|
|
2024
Q1 | $1.16M | Buy |
5,371
+71
| +1% | +$15.3K | 0.19% | 226 |
|
|
2023
Q4 | $1.37M | Sell |
5,300
-80
| -1% | -$20.7K | 0.26% | 168 |
|
|
2023
Q3 | $1.38M | Buy |
5,380
+1,599
| +42% | +$411K | 0.31% | 130 |
|
|
2023
Q2 | $1.08M | Buy |
3,781
+16
| +0.4% | +$4.56K | 0.24% | 178 |
|
|
2023
Q1 | $1.05M | Buy |
3,765
+94
| +3% | +$26.1K | 0.26% | 166 |
|
|
2022
Q4 | $1.02M | Buy |
+3,671
| New | +$1.02M | 0.29% | 151 |
|